argenx Management to Present at Upcoming Virtual Investor Conferences

Rhea-AI Summary

On September 2, 2020, argenx (Euronext & Nasdaq: ARGX) announced participation in key healthcare conferences. Management will conduct a fireside chat at the Baird Global Healthcare Conference on September 9 at 12:15 p.m. ET, followed by the Morgan Stanley Global Healthcare Conference on September 14 at 1:30 p.m. ET and BofA Global Healthcare Conference on September 17 at 10:50 a.m. BST. Lastly, a panel will take place at the Stifel Immunology & Inflammation Summit on October 1 at 11:00 a.m. ET. More details are available on the company’s website.

September 2, 2020

Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in several upcoming conferences:

• Baird Global Healthcare Conference. Fireside chat on Wednesday, September 9, 2020 at 12:15 p.m. ET.
• Morgan Stanley Global Healthcare Conference. Fireside chat on Monday, September 14, 2020 at 1:30 p.m. ET.
• BofA Global Healthcare Conference. Fireside chat on Thursday, September 17, 2020 at 10:50 a.m. BST.
• Stifel Immunology & Inflammation Summit. Panel on Thursday, October 1, 2020 at 11:00 a.m. ET.

Additional information regarding these events will be available on the Company’s website at www.argenx.com.

About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States and Japan. For more information, visit www.argenx.com and follow us on LinkedIn at https://www.linkedin.com/company/argenx/.

For further information, please contact:

Beth DelGiacco, Vice President, Investor Relations (US)
+1 518 424 4980
bdelgiacco@argenx.com

Joke Comijn, Director Corporate Communications & Investor Relations (EU)
+32 (0)477 77 29 44
+32 (0)9 310 34 19
jcomijn@argenx.com

FAQ

What conferences is argenx participating in September 2020?

argenx will participate in the Baird Global Healthcare Conference on September 9, Morgan Stanley Global Healthcare Conference on September 14, and BofA Global Healthcare Conference on September 17, 2020.

When will argenx hold a fireside chat at the Baird Global Healthcare Conference?

The fireside chat at the Baird Global Healthcare Conference will be held on September 9, 2020, at 12:15 p.m. ET.

What is the schedule for the upcoming events for ARGX in 2020?

The upcoming events for ARGX include a fireside chat at the Morgan Stanley Global Healthcare Conference on September 14 at 1:30 p.m. ET, and at the BofA Global Healthcare Conference on September 17 at 10:50 a.m. BST.

What is the date and time for argenx's participation in the Stifel Immunology & Inflammation Summit?

argenx will participate in the Stifel Immunology & Inflammation Summit on October 1, 2020, at 11:00 a.m. ET.